title: [Changes in reperfusion strategies in the acute phase of myocardial infarction from 1988 to 2001].
abstract: The objective of this study was to evaluate the evolution of therapeutic strategies in the course of myocardial infarction. Two successive periods were studied: 1988/96 (700 patients) and 1996/2001 (700 patients). The following parameters were compared: patient characteristics, management methods, and results on the hospital morbidity and mortality. The patient characteristics were little changed, in terms of age and sex, with a drop in the frequency of anterior infarcts during the second period (46 vs 51%, p = 0.0001). The average delay to admission remained stable over both periods, 186 vs 189 min. During the second period, primary angioplasty was favoured (66 versus 44%, p = 0.0001), associated with a wider use of stents (47 against 4%, p = 0.0001) and anti GP IIb/IIIa (24 against 0.5%, p = 0.0001). In the acute phase, TIMI3 reperfusion was obtained in 81% of cases (88/96 period) against 88% during the second period (p = 0.02). The hospital mortality was reduced by 1.2% (8.9 against 7.7%, NS). Without cardiogenic shock, the mortality was comparable between the two groups (5%), whereas it diminished in the small group of patients (5%) in cardiogenic shock, from 76 to 66% (NS). Haemorrhagic complications were reduced, but the rate of symptomatic reocclusion remained stable (2.5%). With multivariate analysis, the independent predictive mortality factors were identical in the two groups: age and cardiogenic shock on admission. Currently, TIMI3 reperfusion is possible in close to 90% of patients in the acute phase of infarction. Our efforts should focus on earlier management, especially for older patients, too often excluded without reason, and for those in cardiogenic shock, which constitutes a therapeutic quest for the future. The theory of angioplasty facilitated by anti GP IIb/IIIa and/or prehospital thrombolysis must be evaluated scientifically with the goal of early and efficient reperfusion for the greatest number of patients.
authors.affiliation: Département de cardiologie, Pr Alec Vahanian, hôpital Bichat, AP-HP, 46, rue Henri Huchard, 75877 Paris. jean-michel.juliard@bch.aphop-paris.fr
authors.forename: J M
authors.initials: JM
authors.lastname: Juliard
authors.forename: P
authors.initials: P
authors.lastname: Aubry
authors.forename: J L
authors.initials: JL
authors.lastname: Golmard
authors.forename: D
authors.initials: D
authors.lastname: Himbert
authors.forename: H
authors.initials: H
authors.lastname: Benamer
authors.forename: L J
authors.initials: LJ
authors.lastname: Feldman
authors.forename: O
authors.initials: O
authors.lastname: Boudvillain
authors.forename: T
authors.initials: T
authors.lastname: Haghighat
authors.forename: A
authors.initials: A
authors.lastname: Ricard-Hibon
authors.forename: P G
authors.initials: PG
authors.lastname: Steg
mesh_terms: D000368:Aged; D015331:Cohort Studies; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D015425:Myocardial Reperfusion / Q000009:adverse effects / Q000379:methods* / Q000639:trends; D011183:Postoperative Complications / Q000453:epidemiology